Oral Antibiotics Cut Hospital Stay for Kids With Pneumonia
A major international clinical trial, the PediCAP study, found that children hospitalized with severe pneumonia can safely transition from injectable to oral antibiotics once they begin to recover. This change could reduce hospital stays, lower healthcare costs, and decrease the risk of hospital-acquired infections.
Why it matters
Implementing this protocol could significantly improve pediatric care outcomes and resource allocation in low- and middle-income countries.
Children hospitalised with severe pneumonia can safely switch from injectable to oral antibiotics once they begin to recover, allowing many to return home sooner and complete treatment outside hospital. This is according to a major international clinical trial led by researchers from City St George's, University of London, UCL Innovative Clinical Trials Unit, and partners across Africa and Europe, with results published today in The Lancet.
Pneumonia remains one of the leading infectious killers of children worldwide, particularly in low- and middle-income countries. Current World Health Organization (WHO) guidelines recommend five days of injectable antibiotics for children hospitalised with severe community-acquired pneumonia, often requiring them to stay in hospital even after they have already substantially improved.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in